北米の四肢麻痺ケア機器市場 - 業界分析、規模、シェア、成長、動向、予測（2031年）- 製品別、適応症別、エンドユーザー別、国別

北米の四肢麻痺ケア機器の市場規模は、脊髄損傷の有病率の上昇と継続的な技術進歩により、大幅な成長が見込まれています。同市場は2024年までに5億686万米ドルに達し、2031年までに7億4,100万米ドルに成長するとみられ、5.6％の安定した年間平均成長率（CAGR）で拡大すると予測されています。この成長の原動力となっているのは、四肢麻痺患者の移動性、快適性、全体的な生活の質を高めるために調整された病院用ベッドや特殊医療機器に対する旺盛な需要です。

市場力学市場の成長軌道を支えているのは、北米で毎年報告される脊髄損傷症例の増加です。National Spinal Cord Injury Statistical Center（国立脊髄損傷統計センター）のデータによると、毎年数千件の脊髄損傷症例が新たに記録されており、ロボットアームシステム、義肢装具、その他の補助装置などの高度な医療ソリューションが必要とされています。これらの技術革新は、四肢麻痺患者特有のニーズに対応し、より包括的で協力的なヘルスケア環境を促進します。

販売分析と市場見通し過去5年間、北米の四肢麻痺ケア機器市場は、専門的ケアに対する需要の高まりを反映し、安定したペースで拡大してきました。2016年から2020年までの売上高分析では、脊髄損傷の有病率の上昇や医療技術の進歩などの要因によって、これらの機器の導入が一貫して増加していることが強調されています。今後も、患者の予後を改善する最先端のソリューションの提供に重点を置きながら、市場は上昇基調を続けると予想されます。

当レポートでは、北米の四肢麻痺ケア機器市場について調査し、市場の概要とともに、製品別、適応症別、エンドユーザー別、国別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

• 市場の定義とセグメンテーション
• 市場力学
• サポートとケアのための新しい技術
• 規制シナリオ
• バリューチェーン分析
• ポーターのファイブフォース分析
• COVID-19の影響分析
• 経済概要
• PESTLE分析

第3章 価格分析、2018年～2024年

第4章 北米の四肢麻痺ケア機器市場の見通し、2018年～2031年

• 北米の四肢麻痺ケア機器市場の見通し、製品別、金額（10億米ドル）、数量（台）、2018年～2031年
• 北米の四肢麻痺ケア機器市場の見通し、適応症別、金額（10億米ドル）、2018年～2031年
• 北米の四肢麻痺ケア機器市場の見通し、エンドユーザー別、金額（10億米ドル）、2018年～2031年
• 北米の四肢麻痺ケア機器市場の見通し、国別、金額（10億米ドル）、数量（台）、2018年～2031年

第5章 米国の四肢麻痺ケア機器市場の見通し、2018年～2031年

第6章 カナダの四肢麻痺ケア機器市場の見通し、2018年～2031年

第7章 競合情勢

• 企業市場シェア分析、2024年
• 競合ダッシュボード
• 企業プロファイル
  • ReWalk Robotics
  • Ekso Bionics
  • Indego
  • Rex Bionics Ltd.
  • Caltech
  • Ossur
  • Steeper Inc
  • Boston Scientific Corporation
  • Medtronic Plc
  • Ottobock
  • RGK Wheelchair

第8章 付録

The North American quadriplegia care devices market is poised for substantial growth, driven by the increasing prevalence of spinal cord injuries and ongoing technological advancements. Projected by Fairfield Market Research, the market is expected to reach $506.86 million by 2024, growing to $741 million by 2031, reflecting a steady compound annual growth rate (CAGR) of 5.6%. This growth is fueled by robust demand for hospital beds and specialized medical equipment tailored to enhance mobility, comfort, and overall quality of life for quadriplegic patients.

Market Dynamics The market's growth trajectory is supported by the increasing number of spinal cord injury cases reported annually in North America. According to data from the National Spinal Cord Injury Statistical Center, thousands of new spinal cord injury cases are recorded each year, necessitating advanced medical solutions such as robotic arm systems, prosthetics, and other assistive devices. These innovations cater to the unique needs of quadriplegic patients, fostering a more inclusive and supportive healthcare environment.

Sales Analysis and Market Outlook Over the past five years, the North American market for quadriplegia care devices expanded at a steady pace, reflecting the growing demand for specialized care. The sales analysis from 2016 to 2020 highlights a consistent increase in the adoption of these devices, driven by factors such as the rising prevalence of spinal cord injuries and advancements in medical technology. Looking ahead, the market is expected to continue its upward trajectory, with a focus on delivering cutting-edge solutions that improve patient outcomes.

Technological Advancements Driving Market Growth Technological innovations are at the heart of the market's growth, with recent developments in computer science, robotics, artificial intelligence, and sensor technology broadening the range of applications for quadriplegia care devices. Powered wheelchairs, for example, have revolutionized mobility for quadriplegic patients by incorporating control and navigational intelligence. These advanced devices are designed to enhance efficiency, reduce stress, and offer greater flexibility, thereby improving the overall quality of life for users.

Product Innovations and Market Opportunities The market is witnessing a surge in product innovations aimed at addressing the specific needs of quadriplegic patients. For instance, the introduction of new orthopaedic braces with hot and cold therapy features has significantly improved patient comfort and treatment outcomes. These dual-feature braces are set to dominate the market, replacing conventional systems and driving future growth.

Key Opportunities for Manufacturers The increasing prevalence of spinal cord injuries and the rapid pace of technological advancements present significant opportunities for quadriplegia care device manufacturers. The widespread acceptance and adoption of these advanced devices, driven by rigorous research and early product launches, are creating a fertile ground for market expansion. Additionally, the efforts of non-governmental organizations (NGOs) to raise awareness about conditions such as osteoporosis are expected to further boost the demand for quadriplegia care solutions.

Challenges and Restraints Despite the promising growth prospects, the market faces several challenges. High costs associated with advanced braces and the regulatory hurdles imposed by agencies such as the FDA are significant barriers to market entry for new players. Additionally, the availability of second-hand quadriplegia care devices, often donated or resold, poses a challenge to the growth of new product sales. However, these challenges also present opportunities for manufacturers to innovate and develop cost-effective solutions that comply with regulatory standards.

Country-wise Insights The U.S. dominates the North American quadriplegia care devices market, driven by a high incidence of quadriplegia and a strong healthcare infrastructure. The country's market share is bolstered by the consolidation among healthcare providers and the widespread adoption of advanced devices to reduce healthcare costs. Meanwhile, Canada, with a notable incidence of spinal cord injuries, represents a growing market for quadriplegia care devices. The increasing number of spinal cord injury cases in Canada is expected to drive demand for advanced treatment solutions.

Product and Indication Analysis Hospital beds are among the most in-demand quadriplegia care products, accounting for a significant market share. These technologically-advanced beds, designed specifically for paraplegic and quadriplegic care, provide enhanced comfort and improved health outcomes. In terms of indications, sports injuries and car accidents are the most common causes of incomplete quadriplegia, driving the demand for specialized care devices.

Competitive Analysis

• ReWalk Robotics
• Ekso Bionics
• Indego (Parker Hannifin Corporation)
• Rex Bionics Ltd.
• Caltech
• Ossur
• Steeper, Inc.
• Boston Scientific corporation
• Medtronic Plc.
• Ottobock
• RGK Wheelchairs
• Rifton Equipment
• Allard USA, Inc.
• Fillauer LLC
• College Park Industries
• Mobius Bionics.
• Parker Hannifin
• Nevro
• ProBed Medical Technologies Inc.
• BLUE CHIP MEDICAL
• Restorative Therapies
• MYOLYN, LLC

Key Segments in North America Quadriplegia Care Devices Industry Survey

North America Quadriplegia Care Devices Market by Product:

• Stimulation Devices
  • Spinal Cord Stimulators
  • Functional Electrical Stimulation (FES) Systems
• Assistive Devices
  • Exoskeletons
  • Robotic Arm Systems
  • Prosthetics

§ Upper Limb Prosthetics

§ Lower Limb Prosthetics

• Mobility Devices
  • Wheelchairs
  • Crutches & Walkers
  • Gait Trainers
• Hospital Beds
• Transfer Bench and Boards
• Braces & Supports
• Orthopaedic Splints
• Others Supportive Devices

North America Quadriplegia Care Devices Market by Indication:

• Incomplete Quadriplegia
• Complete Quadriplegia

North America Quadriplegia Care Devices Market by End User:

• Rehabilitation Centres
• Assistive Living Facilities
• Long-term Care Centers
• Home Care Settings

North America Quadriplegia Care Devices Market by Country:

• U.S Quadriplegia Care Devices Market
• Canada Quadriplegia Care Devices Market

Table of Contents

1. Executive Summary

• 1.1. North America Quadriplegia Care Devices Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value and Volume, 2024
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Emerging Technologies for Support & Care
• 2.4. Regulatory Scenario
• 2.5. Value Chain Analysis
• 2.6. Porter's Five Forces Analysis
• 2.7. COVID-19 Impact Analysis
  • 2.7.1. Supply
  • 2.7.2. Demand
• 2.8. Economic Overview
  • 2.8.1. World Economic Projections
• 2.9. PESTLE Analysis

3. Price Analysis, 2018 - 2024

• 3.1. North America Average Price Analysis, by Product, US$ Per Unit, 2018 - 2024
• 3.2. Prominent Factor Affecting Quadriplegia Care Devices Prices
• 3.3. North America Average Price Analysis, by Region, US$ Per Unit

4. North America Quadriplegia Care Devices Market Outlook, 2018 - 2031

• 4.1. North America Quadriplegia Care Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  • 4.1.1. Key Highlights
    • 4.1.1.1. Stimulation Devices
    • 4.1.1.2. Assistive Devices
    • 4.1.1.3. Mobility Devices
    • 4.1.1.4. Hospital Beds
    • 4.1.1.5. Transfer Bench and Boards
    • 4.1.1.6. Braces & Supports
    • 4.1.1.7. Orthopaedic Splints
    • 4.1.1.8. Others Supportive Devices
• 4.2. North America Quadriplegia Care Devices Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
  • 4.2.1. Key Highlights
    • 4.2.1.1. Incomplete Quadriplegia
    • 4.2.1.2. Complete Quadriplegia
• 4.3. North America Quadriplegia Care Devices Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
  • 4.3.1. Key Highlights
    • 4.3.1.1. Rehabilitation Centres
    • 4.3.1.2. Assistive Living Facilities
    • 4.3.1.3. Long-term Care Centres
    • 4.3.1.4. Home Care Settings
• 4.4. North America Quadriplegia Care Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
  • 4.4.1. Key Highlights
    • 4.4.1.1. U.S.
    • 4.4.1.2. Canada

5. U.S. Quadriplegia Care Devices Market Outlook, 2018 - 2031

• 5.1. U.S. Quadriplegia Care Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  • 5.1.1. Key Highlights
    • 5.1.1.1. Stimulation Devices
    • 5.1.1.2. Assistive Devices
    • 5.1.1.3. Mobility Devices
    • 5.1.1.4. Hospital Beds
    • 5.1.1.5. Transfer Bench and Boards
    • 5.1.1.6. Braces & Supports
    • 5.1.1.7. Orthopaedic Splints
    • 5.1.1.8. Others Supportive Devices
• 5.2. U.S. Quadriplegia Care Devices Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
  • 5.2.1. Key Highlights
    • 5.2.1.1. Incomplete Quadriplegia
    • 5.2.1.2. Complete Quadriplegia
• 5.3. U.S. Quadriplegia Care Devices Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
  • 5.3.1. Key Highlights
    • 5.3.1.1. Rehabilitation Centres
    • 5.3.1.2. Assistive Living Facilities
    • 5.3.1.3. Long-term Care Centres
    • 5.3.1.4. Home Care Settings
  • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Canada Quadriplegia Care Devices Market Outlook, 2018 - 2031

• 6.1. Canada Quadriplegia Care Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  • 6.1.1. Key Highlights
    • 6.1.1.1. Stimulation Devices
    • 6.1.1.2. Assistive Devices
    • 6.1.1.3. Mobility Devices
    • 6.1.1.4. Hospital Beds
    • 6.1.1.5. Transfer Bench and Boards
    • 6.1.1.6. Braces & Supports
    • 6.1.1.7. Orthopaedic Splints
    • 6.1.1.8. Others Supportive Devices
• 6.2. Canada Quadriplegia Care Devices Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
  • 6.2.1. Key Highlights
    • 6.2.1.1. Incomplete Quadriplegia
    • 6.2.1.2. Complete Quadriplegia
• 6.3. Canada Quadriplegia Care Devices Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
  • 6.3.1. Key Highlights
    • 6.3.1.1. Rehabilitation Centres
    • 6.3.1.2. Assistive Living Facilities
    • 6.3.1.3. Long-term Care Centres
    • 6.3.1.4. Home Care Settings
  • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Competitive Landscape

• 7.1. Company Market Share Analysis, 2024
• 7.2. Competitive Dashboard
• 7.3. Company Profiles
  • 7.3.1. ReWalk Robotics
    • 7.3.1.1. Company Overview
    • 7.3.1.2. Product Portfolio
    • 7.3.1.3. Financial Overview
    • 7.3.1.4. Business Strategies and Development
  • 7.3.2. Ekso Bionics
    • 7.3.2.1. Company Overview
    • 7.3.2.2. Product Portfolio
    • 7.3.2.3. Financial Overview
    • 7.3.2.4. Business Strategies and Development
  • 7.3.3. Indego (Parker Hannifin Corporation)
    • 7.3.3.1. Company Overview
    • 7.3.3.2. Product Portfolio
    • 7.3.3.3. Financial Overview
    • 7.3.3.4. Business Strategies and Development
  • 7.3.4. Rex Bionics Ltd.
    • 7.3.4.1. Company Overview
    • 7.3.4.2. Product Portfolio
    • 7.3.4.3. Financial Overview
    • 7.3.4.4. Business Strategies and Development
  • 7.3.5. Caltech
    • 7.3.5.1. Company Overview
    • 7.3.5.2. Product Portfolio
    • 7.3.5.3. Financial Overview
    • 7.3.5.4. Business Strategies and Development
  • 7.3.6. Ossur
    • 7.3.6.1. Company Overview
    • 7.3.6.2. Product Portfolio
    • 7.3.6.3. Financial Overview
    • 7.3.6.4. Business Strategies and Development
  • 7.3.7. Steeper Inc
    • 7.3.7.1. Company Overview
    • 7.3.7.2. Product Portfolio
    • 7.3.7.3. Financial Overview
    • 7.3.7.4. Business Strategies and Development
  • 7.3.8. Boston Scientific Corporation
    • 7.3.8.1. Company Overview
    • 7.3.8.2. Product Portfolio
    • 7.3.8.3. Financial Overview
    • 7.3.8.4. Business Strategies and Development
  • 7.3.9. Medtronic Plc
    • 7.3.9.1. Company Overview
    • 7.3.9.2. Product Portfolio
    • 7.3.9.3. Financial Overview
    • 7.3.9.4. Business Strategies and Development
  • 7.3.10. Ottobock
    • 7.3.10.1. Company Overview
    • 7.3.10.2. Product Portfolio
    • 7.3.10.3. Financial Overview
    • 7.3.10.4. Business Strategies and Development
  • 7.3.11. RGK Wheelchair
    • 7.3.11.1. Company Overview
    • 7.3.11.2. Product Portfolio
    • 7.3.11.3. Financial Overview
    • 7.3.11.4. Business Strategies and Development

8. Appendix

• 8.1. Research Methodology
• 8.2. Report Assumptions
• 8.3. Acronyms and Abbreviations